在治療第一型的肝腎症候群時,應考慮滴注白蛋白合併血管收縮藥物,如 terlipressin (I), octreotide 及 midodrine (III)。 Albumin infusion plus administration of vasoactive drugs such as terlipressin (I), octreotide and midodrine (III) should be considered in the treatment of type I hepatorenal syndrome.